Abstract Title:

Rational Drug Discovery: Ellagic Acid As A Potent Dual-target Inhibitor against Hepatitis C Virus Genotype 3 (HCV G3) NS3 Enzymes.

Abstract Source:

Chem Biol Drug Des. 2020 Jul 13. Epub 2020 Jul 13. PMID: 32657543

Abstract Author(s):

See Khai Lim, Rozana Othman, Rohana Yusof, Choon Han Heh

Article Affiliation:

See Khai Lim


Structure-based virtual screening (SBVS) has served as a popular strategy for rational drug discovery. In this study, we aimed to discover novel benzopyran-based inhibitors that targeted the NS3 enzymes (NS3/4A protease and NS3 helicase) of HCV G3 using a combination of in silico and in vitro approaches. With the aid of SBVS, six novel compounds were discovered to inhibit HCV G3 NS3/4A protease and two phytochemicals (ellagic acid and myricetin) were identified as dual-target inhibitors that inhibited both NS3/4A protease and NS3 helicase in vitro (IC= 40.37± 5.47 nM and 6.58 ± 0.99 µM respectively). Inhibitory activities against the replication of HCV G3 replicons were further assessed in a cell-based system with four compounds showed dose-dependent inhibition. Compound P8 was determined to be the most potent compound from the cell-based assay withan ECof 19.05µM. The dual-target inhibitor, ellagic acid was determined as the second most potent (EC= 32.37µM) and the most selective in its inhibitory activity against the replication of HCV replicons, without severely affecting the viability of the host cells (selectivity index = 6.18).

Study Type : In Vitro Study

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2022 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.